HSGC(SH:600774)2026-01-30 10:25Financial Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -90 million and -60 million yuan, indicating continued losses compared to the previous year [4]. - The estimated net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -49.98 million and -19.98 million yuan [5]. - In the previous year, the total profit was -5.4686 million yuan, with a net profit attributable to shareholders of the parent company at -14.5872 million yuan [6]. Goodwill Impairment - The company plans to recognize goodwill impairment for the Wuhan Huake Reproductive Obstetrics Hospital asset group, estimated between 80 million and 90 million yuan, which is the main reason for the projected negative net profit [7]. Audit and Investment Risks - The preliminary financial data has not been audited by an accounting firm and is subject to change [8]. - The company has communicated with the annual audit accountant and appraisers regarding the performance forecast [8]. - Investors are advised to pay attention to investment risks as the final audited financial data will be disclosed in the 2025 annual report [9].